Earnings NewsHealthcareSurface Oncology EPS beats by $0.07Aug. 11, 2020 6:35 AM ETSurface Oncology, Inc. (SURF) StockSURFBy: Gaurav Batavia, SA News Editor Surface Oncology (NASDAQ:SURF): Q2 GAAP EPS of -$0.44 beats by $0.07. Cash, cash equivalents and marketable securities of $112.5M. Expects current cash and cash equivalents are sufficient to fund the Company into 2022. Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgSURF--Surface Oncology, Inc.Trending AnalysisTrending News